Form 4: enVVeno Medical Corp Director Acquires Stock Options

Director Francis Duhay acquired 19,752 stock options in enVVeno Medical Corp on December 18, 2024, which vest quarterly throughout 2025.

Summary

• Francis Duhay, a director at enVVeno Medical Corp, was granted 19,752 stock options on December 18, 2024.
• These options were issued under the company's Amended and Restated 2016 Omnibus Incentive Plan.
• The options have an exercise price of $2.57.
• The options will vest in equal quarterly installments on the last day of each fiscal quarter during the 2025 calendar year.
• The options expire on December 18, 2034.

Sentiment

Score: 7

Explanation: The document reflects a standard practice of stock option grants to directors, which is generally viewed positively as it aligns interests with shareholders. There are no negative implications.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Industry Context

Stock option grants to directors are a common practice in publicly traded companies to incentivize performance and align interests with shareholders.

Comparison to Industry Standards

• Stock option grants are a standard form of compensation for directors in publicly traded companies.
• The vesting schedule of quarterly installments over a year is a typical approach to encourage long-term commitment.
• The 10-year expiration period is also a common practice for stock options.

Stakeholder Impact

• The stock option grant aligns the director's interests with those of the shareholders, potentially leading to better performance and increased shareholder value.

Key Dates

Keywords

stock options, director, insider trading, equity, vesting, enVVeno Medical Corp, NVNO